Literature DB >> 25066121

A mitochondrial switch promotes tumor metastasis.

Paolo E Porporato1, Valéry L Payen1, Jhudit Pérez-Escuredo1, Christophe J De Saedeleer1, Pierre Danhier2, Tamara Copetti1, Suveera Dhup1, Morgane Tardy1, Thibaut Vazeille1, Caroline Bouzin1, Olivier Feron1, Carine Michiels3, Bernard Gallez2, Pierre Sonveaux4.   

Abstract

Metastatic progression of cancer is associated with poor outcome, and here we examine metabolic changes underlying this process. Although aerobic glycolysis is known to promote metastasis, we have now identified a different switch primarily affecting mitochondria. The switch involves overload of the electron transport chain (ETC) with preserved mitochondrial functions but increased mitochondrial superoxide production. It provides a metastatic advantage phenocopied by partial ETC inhibition, another situation associated with enhanced superoxide production. Both cases involved protein tyrosine kinases Src and Pyk2 as downstream effectors. Thus, two different events, ETC overload and partial ETC inhibition, promote superoxide-dependent tumor cell migration, invasion, clonogenicity, and metastasis. Consequently, specific scavenging of mitochondrial superoxide with mitoTEMPO blocked tumor cell migration and prevented spontaneous tumor metastasis in murine and human tumor models.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25066121     DOI: 10.1016/j.celrep.2014.06.043

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  215 in total

Review 1.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

Review 2.  Serine and one-carbon metabolism in cancer.

Authors:  Ming Yang; Karen H Vousden
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

3.  CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.

Authors:  Heather J Wright; Jue Hou; Binzhi Xu; Marvin Cortez; Eric O Potma; Bruce J Tromberg; Olga V Razorenova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 4.  Mitophagy in tumorigenesis and metastasis.

Authors:  Logan P Poole; Kay F Macleod
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

Review 5.  Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.

Authors:  Satish Srinivasan; Manti Guha; Anna Kashina; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-01-16       Impact factor: 3.991

Review 6.  ROS in Cancer: The Burning Question.

Authors:  Iok In Christine Chio; David A Tuveson
Journal:  Trends Mol Med       Date:  2017-04-17       Impact factor: 11.951

Review 7.  Mitochondrial Involvement in Migration, Invasion and Metastasis.

Authors:  Tatiana V Denisenko; Anna S Gorbunova; Boris Zhivotovsky
Journal:  Front Cell Dev Biol       Date:  2019-12-20

8.  Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.

Authors:  Dongya Jia; Mingyang Lu; Kwang Hwa Jung; Jun Hyoung Park; Linglin Yu; José N Onuchic; Benny Abraham Kaipparettu; Herbert Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-07       Impact factor: 11.205

9.  Deficiency of mitochondrial modulator MCJ promotes chemoresistance in breast cancer.

Authors:  Maria J Fernández-Cabezudo; Issam Faour; Kenneth Jones; Devin P Champagne; Mohammed A Jaloudi; Yassir A Mohamed; Ghada Bashir; Saeeda Almarzooqi; Alia Albawardi; M Jawad Hashim; Thomas S Roberts; Haytham El-Salhat; Hakam El-Taji; Adnan Kassis; Dylan E O'Sullivan; Brock C Christensen; James DeGregori; Basel K Al-Ramadi; Mercedes Rincon
Journal:  JCI Insight       Date:  2016-05-19

Review 10.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.